Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade.

Cancer medicine - 1 Apr 2021

Buchbinder Elizabeth I, Weirather Jason L, Manos Michael, Quattrochi Brian J, Sholl Lynette M, Brennick Ryan C, Bowling Peter, Bailey Nancy, Magarace Lisa, Ott Patrick A, Haq Rizwan, Izar Benjamin, Giobbie-Hurder Anita, Hodi F Stephen

Abstract excerpt

Mucosal melanoma is a rare form of melanoma which arises from melanocytes in the mucosal membranes and can be effectively treated with immune checkpoint blockade (ICB). However, response rates in mucosal melanoma are lower than those observed for cutaneous melanomas. Targeted sequencing of up to 447 genes (OncoPanel) was performed on tumors from all mucosal melanoma patients seen at the Dana-Farber Cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Immune Checkpoint Inhibitors

Share to Melanoma

Share to Mucous Membrane

Share to Prognosis

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 33724703
DOI: 10.1002/cam4.3789
PMCID: PMC8026918

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade.PMID 33724703Read ↗

Molecular Profiling and Novel Therapeutic Strategies for Mucosal Melanoma: A Comprehensive ReviewSemantic proximity Read ↗

The mutational landscape of mucosal melanoma.Semantic proximity Read ↗

Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.Semantic proximity Read ↗

Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targetsSemantic proximity Read ↗

Meta-Analysis and Systematic Review of the Genomics of Mucosal Melanoma.Semantic proximity Read ↗

Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes.Semantic proximity Read ↗

Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma PatientsSemantic proximity Read ↗

Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies.Semantic proximity Read ↗

Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma.Semantic proximity Read ↗

Mutational Characteristics of Primary Mucosal Melanoma: A Systematic Review.Semantic proximity Read ↗

Candidate therapeutic agents in a newly established triple wild‐type mucosal melanoma cell lineSemantic proximity Read ↗

Targeted DNA Sequencing of Cutaneous Melanoma Identifies Prognostic and Predictive AlterationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.